Mr. Ciarán Breen:

Perhaps I might help the Deputy by saying the following. We have asked our actuaries, for the purposes of our strategy committee in the agency, to carry out the kind of examination for which the Deputy has just asked, to look at the cost of claims here relative to the cost in the United Kingdom in both clinical and non-clinical cases. Certainly, the value is lower here for clinical claims than in the United Kingdom. The rate of claims is proportionate both here and there.